Premium
PD‐1 INHIBITOR PLUS CHEMOTHERAPY IN RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) WITH AGGRESSIVE BULKY DISEASE
Author(s) -
Mei Q.,
Zhang W.,
Liu Y.,
Liu J.,
Yang Q.,
Han W.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.78_2630
Subject(s) - medicine , rituximab , vinorelbine , refractory (planetary science) , regimen , salvage therapy , gemcitabine , oncology , lymphoma , aggressive lymphoma , chemotherapy , adverse effect , population , surgery , physics , environmental health , astrobiology , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom